treprostinil diolamine prodrug (United Therapeutics)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nametreprostinil diolamine prodrug (United Therapeutics)
Drug Alias NameOreniPro
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstanoid IP receptor agonists
TargetsProstanoid IP receptor
Therapy Area/IndicationsPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEurope
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUnited Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesUnited Therapeutics Corp
Inactive CompaniesN/A
Active IndicationsPulmonary Arterial Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A